Neutrophil-to-lymphocyte ratio as an early marker of outcomes in patients with recurrent oral squamous cell carcinoma treated with nivolumab
Hidetake Tachinami, Kei Tomihara, Shin‐ichi Yamada, Atsushi Ikeda, Shuichi Imaue, Hideaki Hirai, Hiromi Nakai, Tomoko Sonoda, Kazuto Kurohara, Yukio Yoshioka, Takumi Hasegawa, Tomofumi Naruse, Takashi Niiyama, Tetsu Shimane, Michihiro Ueda, Souichi Yanamoto, Masaya Akashi, Masahiro Umeda, Hiroshi Kurita, Akihiro Miyazaki, Naoya Arai, Ryuji Hayashi, Makoto Noguchi
Topics & Concepts
MedicineNivolumabInternal medicineNeutrophil to lymphocyte ratioCancerOncologyProgressive diseaseGastroenterologyRetrospective cohort studyPredictive markerResponse Evaluation Criteria in Solid TumorsChemotherapyLymphocyteImmunotherapyCancer Immunotherapy and BiomarkersInflammatory Biomarkers in Disease PrognosisImmune cells in cancer